Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Metabolic syndrome, leaky guts, and infection: Metabolic syndrome often accompanies obesity and hyperglycemia and is associated with a breakdown in the integrity of the intestinal barrier and increased risk of systemic infection. Thaiss et al. found that mice with systemic infection of a Salmonella analog, Citrobacter rodentium , also exhibited hyperglycemia. Deletion of the glucose transporter GLUT2 altered sensitivity to chemically induced epithelial permeability and protected mice from pathogen invasion. The authors also found a correlation in humans between glycated hemoglobin (an indicator of hyperglycemia) and serum levels of pathogen recognition receptor ligands. Science , this issue p. 1376
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thaiss et al. clearly showed that hyperglycemia drives intestinal permeability by the glucose transporter GLUT2-dependent transcriptional reprogramming of intestinal epithelial cells, resulting in changes in tight and adherence junction integrity, and a systemic influx of microbial products into portal blood [274].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [274]
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Inflammation, metaflammation and immunometabolic disorders
Hotamisligil, G. S. (2017) · Nature · doi:10.1038/nature21363 · Cited by 2,570
Massively parallel single-cell RNA-seq for marker-free decomposition of tissues into cell types
Jaitin, D. A., Kenigsberg, E., Keren-Shaul, H., Elefant, N., Paul, F., Zaretsky, I., Mildner, A., Cohen, N., Jung, S., Tanay, A., et al. (2014) · Science · doi:10.1126/science.1247651 · Cited by 1,795
Van der Sluis, M., De Koning, B. A. E., De Bruijn, A. C. J. M., Velcich, A., Meijerink, J. P. P., Van Goudoever, J. B., Büller, H. A., Dekker, J., Van Seuningen, I., Renes, I. B., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.020 · Cited by 1,684
Cited by
Items 301–400 of 965
A Metabolite Perspective on the Involvement of the Gut Microbiota in Type 2 Diabetes
Fu, Y., Li, S., Xiao, Y., Liu, G., & Fang, J. Q. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914991 · Cited by 34
“The integrity of TJ and adherent junctions is inhibited by organismal hyperglycemia in a way that is dependent on the bidirectional glucose transporter protein (GLUT2) in T2D [52].”
BackgroundMcClintock, S. D., Dame, M. K., Richter, A., Attili, D., Silvestri, S. S., Berner, M. M., Bohm, M. S., Karpoff, K., McCarthy, C. L., Spence, J. R., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0222058 · Cited by 35
“, as a consequence of high-fat diets [45], hyperglycemia [46], psychological stress [47] and hypoxia [48].”
BackgroundTung, Y., Zeng, J., Ho, S., Xu, J.-W., Lin, I., & Wu, J. (2021) · Antioxidants · doi:10.3390/antiox11010045 · Cited by 33
“Hyperglycaemia increases intestinal permeability, leading to the reduced expression of tight junction proteins [36].”
BackgroundPeripheral and central regulation of insulin by the intestine and microbiome
Schertzer, J. D., & Lam, T. K. T. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00547.2020 · Cited by 36
Shen, Z., Hou, Y., Zhao, G., Tan, L., Chen, J., Dong, Z., Ni, C., & Pei, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e25459 · Cited by 31
“When this condition was generated in mice with diabetes and obesity, and GLUT-2 was knocked out, the loss of GLUT-2 reversed hyperglycemia and normalized body weight [81].”
BackgroundThe Antidiabetic Potential of Probiotics: A Review
Li, S., Liu, Z., Zhang, Q., Su, D., Wang, P., Li, Y., Shi, W., & Zhang, Q. (2024) · Nutrients · doi:10.3390/nu16152494 · Cited by 31
“Mechanistic studies in mice have shown that hyperglycemia may increase intestinal barrier permeability by disrupting the tight junction integrity of glucose transporter 2 (GLUT2)-dependent intestinal epithelial cells, leading to mucosal leakage [27].”
BackgroundNatural solutions for diabetes: the therapeutic potential of plants and mushrooms
Sknepnek, A., Miletić, D., Stupar, A., Salević-Jelić, A. S., Nedović, V., & Cvetanović, A. D. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1511049 · Cited by 35
A pregnancy complication-dependent change in SIgA-targeted microbiota during third trimester
Cui, M., Qi, C., Yang, L., Zhang, M., Wang, H., She, G., Yu, R., Miao, T., & Sun, J. (2020) · Food & Function · doi:10.1039/c9fo02919b · Cited by 35
Latorre, J., Lluch, A., Ortega, F. J., Gavaldà‐Navarro, A., Comas, F., Morón‐Ros, S., Rodrı́guez, A., Becerril, S., Villarroya, F., Frühbeck, G., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105486 · Cited by 30
Jiang, T., Li, Y., Li, L., Liang, T., Du, M., Yang, L., Yang, J., Yang, R., Zhao, H., Chen, M., et al. (2022) · Nutrients · doi:10.3390/nu14194050 · Cited by 32
“Hyperglycemia increases intestinal permeability in obese and diabetic mice leading to microbial metabolites entering the host and increasing the risk of infection [66].”
BackgroundBootz-Maoz, H., Pearl, A., Melzer, E., Malnick, S. D. H., Sharon, E., Bennet, Y., Tsentsarevsky, R., Abuchatzera, S., Amidror, S., Aretz, E., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111657 · Cited by 32
Dubois, N., Muñoz-García, J., Heymann, D., & Renodon‐Cornière, A. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115765 · Cited by 29
Gut microbiota interacts with inflammatory responses in acute pancreatitis
Wu, L., Hu, J., Yi, X.-L., Lv, J., Yao, J., Tang, W., Zhang, S., & Wan, M. (2023) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848231202133 · Cited by 33
High sugar diets can increase susceptibility to bacterial infection in Drosophila melanogaster
Darby, A. M., Okoro, D. O., Aredas, S., Frank, A. M., Pearson, W. H., Dionne, M., & Lazzaro, B. P. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012447 · Cited by 29
Gut microbiota-derived metabolites as key mucosal barrier modulators in obesity
Wei, Y., Zheng, K., & Wang, Y.-G. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i33.5555 · Cited by 35
Scheithauer, T. P. M., Davids, M., Winkelmeijer, M., Verdoes, X., Aydin, Ö., de Brauw, M., van de Laar, A. W. J. M., Meijnikman, A. S., Gerdes, V. E. A., van Raalte, D. H., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2031696 · Cited by 29
“(2018) proposed a mechanism how hyperglycemia reduces the intestinal barrier function.(30) Therefore, there is a strong association between inflammation, gut microbiome and hyperglycemia.”
Excess Dietary Sugar Alters Colonocyte Metabolism and Impairs the Proliferative Response to Damage
Burr, A. B. P., Ji, J., Ozler, K., Mentrup, H. L., Eskiocak, O., Yueh, B., Cumberland, R. L., Menk, A. V., Rittenhouse, N., Marshall, C. W., et al. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.05.001 · Cited by 30
“Excess sugar consumption has been linked to diabetes, and increased blood glucose impairs intestinal integrity.(23) However, when we increased the sugar content in experimental mouse diets, we detected no differences in fasted or postprandial blood glucose levels or in intestinal permeability of mice”
BackgroundHuman gut microbiome: Therapeutic opportunities for metabolic syndrome—Hype or hope?
Horvath, A., Žukauskaitė, K., Hazia, O., Balázs, I., & Stadlbauer, V. (2023) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.436 · Cited by 33
Oral nanomedicine biointeractions in the gastrointestinal tract in health and disease
Chen, C., Beloqui, A., & Xu, Y. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115117 · Cited by 30
Sharma, A., Maurya, C. K., Arha, D., Rai, A. K., Singh, S., Varshney, S., Schertzer, J. D., & Tamrakar, A. K. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.036 · Cited by 29
Human Gut Microbiota in Cardiovascular Disease
Ronen, D., Rokach, Y., Abedat, S., Qadan, A., Daana, S., Amir, O., & Asleh, R. (2024) · Comprehensive physiology · doi:10.1002/cphy.c230012 · Cited by 33
The Collision of Meta-Inflammation and SARS-CoV-2 Pandemic Infection
Huizinga, G. P., Singer, B. H., & Singer, K. (2020) · Endocrinology · doi:10.1210/endocr/bqaa154 · Cited by 28
Kocot, A. M., & Wróblewska, B. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.11.014 · Cited by 28
Berberine Decreases Intestinal GLUT2 Translocation and Reduces Intestinal Glucose Absorption in Mice
Zhang, M., Yang, H., Yang, E., Li, J., & Dong, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010327 · Cited by 29
“We found the feces glucose level was increased after berberine treatment for 6 weeks, which might facilitate the genesis of short chain fatty acid in the large intestine [29], and the resultant lower blood glucose could improve tight junctions between intestinal epithelial cells and reduce damage caused by inflammator…”
BackgroundZhang, R., Chen, Y., Zhang, J., & Liu, J. (2022) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002456 · Cited by 29
Gut microbiome supplementation as therapy for metabolic syndrome
Antony, M. A., Chowdhury, A., Edem, D., Raj, R., Nain, P., Joglekar, M., Verma, V. K., & Kant, R. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i10.1502 · Cited by 31
Lu, Z., Zheng, Y., Zheng, J., Liang, Q., Zhen, Q., Cui, M., Yang, H., Wu, H., Tian, C., Zhu, K., et al. (2024) · Food & Function · doi:10.1039/d3fo05459d · Cited by 29
Maintenance of Intestinal Epithelial Homeostasis by Zinc Transporters
Ohashi, W., Hara, T., Takagishi, T., Hase, K., & Fukada, T. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05561-2 · Cited by 29
Turpin, W., Espin‐Garcia, O., Bedrani, L., Madsen, K. L., Meddings, J. B., Garay, J. A. R., Silverberg, M. S., Smith, M. I., Griffiths, A. M., Moayyedi, P., et al. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz116 · Cited by 29
Probiotics in Adolescent Prediabetes: A Pilot RCT on Glycemic Control and Intestinal Bacteriome
Stefanaki, C., Michos, A. G., Mastorakos, G. P., Mantzou, A., Landis, G., Zosi, P., & Bacopoulou, F. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101743 · Cited by 30
“Hyperglycemia reprograms intestinal epithelial cells via the upregulation of their GLUT-2 receptors resulting in intestinal barrier dysfunction and dysbiotic microbial influx via metaflammation [45].”
BackgroundThe Role of Nutritional Factors and Intestinal Microbiota in Rheumatoid Arthritis Development
Alpizar-Rodriguez, D., Finckh, A., & Gilbert, B. T. P. (2020) · Nutrients · doi:10.3390/nu13010096 · Cited by 31
“Hyperglycemia (mice data) [85] Gliadin (mice data), increases intestinal permeability and exacerbates NSAID-induced small-intestinal damage.”
BackgroundProbiotics as Antioxidant Strategy for Managing Diabetes Mellitus and Its Complications
Viana, M. D. M., Santos, S. S., Cruz, A. B. O., de Jesus, M. V. A. C., Lauria, P. S. S., Lins, M. P., & Villarreal, C. F. (2025) · Antioxidants · doi:10.3390/antiox14070767 · Cited by 31
Stress-induced intestinal barrier dysfunction is exacerbated during diet-induced obesity
Bahlouli, W., Breton, J., Lelouard, M., L’Huillier, C., Tirelle, P., Salameh, É., Amamou, A., Atmani, K., Goichon, A., Bôle‐Feysot, C., et al. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108382 · Cited by 30
Role of Leptin in the Digestive System
Kim, M., & Kim, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.660040 · Cited by 30
“Indeed, ob/ob and db/db mice display diminished intestinal barrier function and increased intestinal permeability relative to wild-type littermates (Thaiss et al., 2018).”
BackgroundZhang, H., Qi, C., Zhao, Y., Lu, M., Li, X., Zhou, J., Dang, H., Cui, M., Miao, T., Sun, J., et al. (2021) · Food & Function · doi:10.1039/d1fo02517a · Cited by 29
Pharmacomicrobiomics and type 2 diabetes mellitus: A novel perspective towards possible treatment
Jia, L., Huang, S., Sun, B., Shang, Y., & Zhu, C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1149256 · Cited by 29
“A previous study, in turn, verified that hyperglycemia drived intestinal barrier permeability through altering the integrity of tight and adherence junctions (49).”
BackgroundHyperglycemia is associated with duodenal dysbiosis and altered duodenal microenvironment
Darra, A., Singh, V., Jena, A., Popli, P., Nada, R., Gupta, P. C., Bhadada, S. K., Singh, A. K., Sharma, V., Bhattacharya, A., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-37720-x · Cited by 32
“In our data, we did not find any difference in zonulin levels between the groups, as observed in previous reports 47 or any association with taxa.”
Silvestri, A., Gil‐Gómez, A., Vitale, M., Braga, D., Demitri, C., Brescia, P., Madaghiele, M., Spadoni, I., Jones, B., Fornasa, G., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101235 · Cited by 31
“7,54,55 Our work shows the potential of using OSH in the treatment of obesity and metabolic disorders as an effective, natural, and non-invasive therapeutic tool.”
BackgroundSha, H., Lü, J., Chen, J., & Xiong, J. (2024) · npj Biofilms and Microbiomes · doi:10.1038/s41522-024-00509-5 · Cited by 29
“Increased expression of junction proteins has been reported to strengthen gut barrier function, which further prevents or reverses pathogen effects 44,45 .”
Li, Y., Chen, G., Hu, X., Bao, Y., Wu, C., Zeng, N., & Jiang, F. (2024) · Scientific Reports · doi:10.1038/s41598-024-59603-5 · Cited by 30
The Gastrointestinal Tract as Prime Site for Cardiometabolic Protection by Dietary Polyphenols
Villa-Rodríguez, J. A., Ifie, I., González-Aguilar, G. A., & Roopchand, D. E. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz038 · Cited by 28
“Subsequently, glucose is taken up by the apically located transporters sodiumdependent glucose cotransporter 1 (SGLT-1) and glucose facilitative transporter 2 (GLUT2).”
BackgroundInfluentialWang, Q., Lin, W., Lei, K., Wang, H., Zhang, X., Jiang, S., Zhang, D., Wang, W., Cao, S., Li, Y., et al. (2024) · Advanced Science · doi:10.1002/advs.202407346 · Cited by 29
Hypoglycemic effect of C. butyricum -pMTL007-GLP-1 engineered probiotics on type 2 diabetes mellitus
Zhou, D., Li, S., Hu, G., Wang, Y., Qi, Z., Xu, X., Wei, J., Liu, Q., & Chen, T. (2025) · Gut Microbes · doi:10.1080/19490976.2024.2447814 · Cited by 30
“46 TJ proteins, the membrane junction complexes between adjacent cells, serve as the essential structural basis for maintaining the mechanical barrier between intestinal mucosal epithelial cells.”
Influence of the microbiome on solid organ transplant survival
Pirozzolo, I., Li, Z., Sepulveda, M., & Alegre, M. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.04.004 · Cited by 27
Imaging therapeutic peptide transport across intestinal barriers
Larsen, J. B., Taebnia, N., Dolatshahi‐Pirouz, A., Eriksen, A. Z., Hjørringgaard, C. U., Kristensen, K., Larsen, N. W., Larsen, N. B., Marie, R., Mündler, A.-K., et al. (2021) · RSC Chemical Biology · doi:10.1039/d1cb00024a · Cited by 27
Liu, M., Wang, L., Huang, B., Lu, Q., & Liu, R. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120742 · Cited by 27
Pedersen, S. S., Prause, M. C. B., Sørensen, C., Størling, J., Möritz, T., Mariño, E., & Billestrup, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054533 · Cited by 28
“Hyperglycemia and gut microbiota dysbiosis drive intestinal barrier dysfunction, allowing the passage of bacterial components and dietary antigens that can trigger an inflammatory response [63,64].”
BackgroundGut Microbiota and Adipose Tissue Microenvironment Interactions in Obesity
Wang, C., Yi, Z., Ye, J., Shen, Z., Yang, F., & Zhu, S. (2023) · Metabolites · doi:10.3390/metabo13070821 · Cited by 26
“This disruption has been directly linked to hyperglycemia and can be remedied by glycemic control [126].”
BackgroundBiomolecular Actions by Intestinal Endotoxemia in Metabolic Syndrome
Charitos, I. A., Aliani, M., Tondo, P., Venneri, M. G., Castellana, G., Scioscia, G., Castellaneta, F., Lacedonia, D., & Carone, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052841 · Cited by 26
“Consequently, this contributes to the production of inflammatory cytokines, recruitment of inflammatory cells, and translocation of bacterial products (LPS, DNA) via intercellular and paracellular pathways, activating inflammation in peripheral tissues [151,152].”
BackgroundZhang, J., Huang, Y. F., Li, H., Xu, P., Liu, Q., Sun, Y., Zhang, Z., Wu, T., Tang, Q., Jia, Q., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50198-z · Cited by 30
“However, one of the poorly understood features of the metabolic syndromes is their association with intestinal barrier dysfunction, which leads to increased intestinal permeability and the transference of microbial molecules into the portal vein blood and liver 4,5 .”
BackgroundMoreira, G. C. M., Salvian, M., Boschiero, C., César, A. S. M., Reecy, J. M., Godoy, T. F., Ledur, M. C., Garrick, D. J., Mourão, G. B., & Coutinho, L. L. (2019) · BMC Genomics · doi:10.1186/s12864-019-6040-3 · Cited by 26
“In mice, changes in glucose levels can lead to a high susceptibility to intestinal barrier dysfunction and enteric infection [68].”
BackgroundCarrageenan and insulin resistance in humans: a randomised double-blind cross-over trial
Wagner, R., Büttner, J., Heni, M., Fritsche, L., Kullmann, S., Wagmüller, M., Peter, A., Preissl, H. T., Machann, J., von Schwartzenberg, R. J., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03771-8 · Cited by 29
“Studies in mice, which were mostly published after initiation of the present study, indicated that intestinal barrier dysfunction is predominantly induced by a high fat diet, hyperglycaemia, and in obesity [19–21].”
Guo, Y. H., Liu, C., Liu, G., Huang, Z., & Zou, D. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12906 · Cited by 25
Kim, T., Silva, S. D. O., Ma, Q., Eller, K., Pollheimer, M. J., Lazarin‐Bidóia, D., Nakamura, C. V., Anders, H., & Steiger, S. (2020) · Cells · doi:10.3390/cells9112481 · Cited by 26
Chen, Y., & Wang, M. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s334325 · Cited by 25
“Thereby, the disruption of the intestinal barrier or the imbalance of gut microbiota would aggravate the progress of diabetes and its complications.(28) Intestinal permeability is usually regulated by tight junction proteins, such as zonula occludens-1 (ZO1), occludin, and claudin-1.”
BackgroundJobe, M., Agbla, S. C., Todorčević, M., Darboe, B., Danso, E., de Barros, J.-P. P., Lagrost, L., Karpe, F., & Prentice, A. M. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01193-1 · Cited by 25
“show that intestinal barrier integrity in diabetic mice is compromised by hyperglycaemia through GLUT-2 transcriptional reprogramming of intestinal epithelial cells [15].”
BackgroundInfluentialWang, R., Santos, J. M., Dufour, J. M., Stephens, E. R., Miranda, J. M., Washburn, R. L., Hibler, T., Kaur, G., Lin, D., & Shen, C. (2022) · Nutrients · doi:10.3390/nu14204384 · Cited by 27
“STZ treatment also resulted in the dysfunction of intestinal epithelial adherence junctions, coupled with systemic dissemination of microbial products, and enhanced trans-epithelial flux [4].”
BackgroundInfluentialObesity-induced hyperglycemia impairs oral tolerance induction and aggravates food allergy
Torres, L., Miranda, M. C. G., Martins, V. D., Caixeta, F., Oliveira, M. D. A., Trindade, L. M., de Assis, H. C., Nascimento, V., Pinheiro-Rosa, N., Gomes, E., et al. (2023) · Mucosal Immunology · doi:10.1016/j.mucimm.2023.05.008 · Cited by 26
Suwal, S., Wu, Q., Liu, W., Liu, Q., Sun, H., Ming, L., Gao, J., Zhang, B., Kou, Y., Liu, Z., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02675 · Cited by 26
“Consistent with the previous report (Thaiss et al., 2018), HFD exacerbated colitis especially in cohort A mice.”
ResultChen, Y., Zheng, Y., Dai, Y.-C., Zhang, Y., & Tang, Z. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i21.2603 · Cited by 25
Zhang, D., Jiang, L., Wang, M., Jin, M., Zhang, X., Liu, D., Wang, Z., Yang, L., & Xu, X. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113206 · Cited by 27
Wang, Y., Tian, L., Fabi, J. P., & de Vos, P. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107539 · Cited by 28
Wurster, J. I., Peterson, R. L., Brown, C. E., Penumutchu, S., Guzior, D. V., Neugebauer, K. A., Sano, W. H., Sebastian, M. M., Quinn, R. A., & Belenky, P. A. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110113 · Cited by 24
Cheng, Y., Tang, S., Wu, T., Pan, S., & Xu, X. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105139 · Cited by 28
Mitochondrial antiviral signaling protein: a potential therapeutic target in renal disease
Wu, M., Pei, Z., Long, G., Chen, H., Jia, Z., & Xia, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1266461 · Cited by 26
Climate Change, Exposome Change, and Allergy
Amini, H., Amini, M., & Wright, R. O. (2023) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2023.09.003 · Cited by 26
Forgie, A. J., Gao, Y., Ju, T., Pepin, D. M., Yang, K., Gänzle, M. G., Ozga, J. A., Chan, C. B., & Willing, B. P. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.01.012 · Cited by 24
Aslam, M. N., McClintock, S. D., Attili, D., Pandya, S., Rehman, H., Nadeem, D. M., Jawad-Makki, M. A. H., Rizvi, A. H., Berner, M. M., Dame, M. K., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.577221 · Cited by 28
“A high-fat diet has been shown to increase intestinal permeability (8) as has hyperglycemia (9).”
BackgroundGil‐Gómez, A., Brescia, P., Rescigno, M., & Romero‐Gómez, M. (2021) · Seminars in Liver Disease · doi:10.1055/s-0041-1723752 · Cited by 26
Alonso, C., Abril-Gil, M., Albert-Bayo, M., Mall, J. G., Expósito, E., González-Castro, A. M., Lobo, B., & Santos, J. (2021) · Advances in Therapy · doi:10.1007/s12325-021-01676-z · Cited by 25
“Indeed, several common gastrointestinal and systemic disorders associated with chronic diarrhea share alterations in the gut epithelial barrier, leading to abnormal intestinal permeability, detachment of mucous layer, intestinal dysbiosis, and, ultimately, low-grade mucosal inflammation [33, 54].”
BackgroundJian, Y., Cheng, L., Hong, Y., Li, Z., Li, C., Ban, X., Zhu, L., & Gu, Z. (2023) · Nutrients · doi:10.3390/nu15245080 · Cited by 26
“Gut function impairment, such as a diminished diversity of gut microbiota and heightened permeability of the gut barrier, is more prevalent in the obese, diabetic, hyperglycemia, and elderly populations [68,69].”
BackgroundGut-bacteria derived membrane vesicles and host metabolic health: a narrative review
Verbunt, J., Jocken, J. W. E., Blaak, E. E., Savelkoul, P. H. M., & Stassen, F. R. M. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2359515 · Cited by 27
Soluble uric acid induces inflammation via TLR4/NLRP3 pathway in intestinal epithelial cells.
Ma, C., Yang, X., Lv, Q., Yan, Z., Chen, Z., Xu, D., Liu, X., Yang, W. Q., & Xing, S. (2020) · PubMed Central · doi:10.22038/ijbms.2020.44948.10482 · Cited by 23
“Increasing data strongly indicate uric acid can also activate NLRP3 inflammasome (21, 22).”
BackgroundD’Antongiovanni, V., Fornai, M., Colucci, R., Nericcio, A., Benvenuti, L., Salvo, C. D., Segnani, C., Pierucci, C., Ippolito, C., Németh, Z. H., et al. (2024) · Acta Physiologica · doi:10.1111/apha.14232 · Cited by 27
“6,17,37,38 In particular, HFD-WT mice showed a significant increase in the expression of NLRP3 inflammasome subunit and active caspase-1 in the colonic tissue, indicating the activation of the well-established pattern of canonical inflammasome pathway.”
Remodelling of colorectal cancer cell signalling by microbiota and immunity in diabetes
Gutiérrez‐Salmerón, M. T., Lucena, S. R., Chocarro‐Calvo, A., García-Martínez, J. M., Orozco, R. M. M., & García‐Jiménez, C. (2021) · Endocrine Related Cancer · doi:10.1530/erc-20-0315 · Cited by 25
Um, C. Y., Hodge, R. A., Tran, H. Q., Campbell, P. T., Gewirtz, A. T., & McCullough, M. L. (2021) · Nutrition and Cancer · doi:10.1080/01635581.2021.1957947 · Cited by 24
“Though not assessed in these studies, these reported associations may be mediated by increased intestinal permeability as experimental and observational evidence suggests that translocation of commensal intestinal bacteria, whether caused by dietary factors or inflammatory bowel disease, triggers an inflammatory casca…”
BackgroundQiao, Z., Wang, X., Wang, C., Jin, H., Qi, W., Zhang, H., Liu, Z., & You, C. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.799053 · Cited by 22
“Wild-type mice fed a 60% fat diet can exhibit not only a damaged gut barrier but also increased inflammatory responses in vivo and a reduced sensitivity of insulin receptors to insulin, which are hyperglycemic symptoms (24).”
BackgroundInteractions of Non-Nutritive Artificial Sweeteners with the Microbiome in Metabolic Syndrome
Harrington, V. M., +, L. L., Crits‐Christoph, A., & Suez, J. (2022) · Immunometabolism · doi:10.20900/immunometab20220012 · Cited by 22
“Indeed, hyperglycemia may promote impaired barrier function [158], and elevated SCFA levels have been suggested to be a marker, rather than a driver, of metabolic syndrome [142].”
BackgroundComprehensive insights: unraveling the mechanisms of gut commensals in glucose metabolism regulation
Li, Z., Nie, Q., & Nie, S. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2455-y · Cited by 22
“Studies have shown that blood glucose levels are associated with an influx of microbial products in humans (Thaiss et al., 2018).”
Sajiir, H., Wong, K. Y., Mueller, A., Keshvari, S., Burr, L. D., Aiello, E., Mezza, T., Giaccari, A., Sebastiani, G., Dotta, F., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48320-2 · Cited by 22
“However, it is important to note that most studies examining gut barrier integrity during impaired glucose metabolism involve obesity or other forms of systemic metabolic stress 29,40,41 .”
Zhang, J., Zhang, R., Chen, Y., Guo, X., Ren, Y., Wang, M., Li, X., Huang, Z., Zhu, W., & Yu, K. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c02381 · Cited by 23
Dietary Effects on Microbiota—New Trends with Gluten-Free or Paleo Diet
Zopf, Y., Reljic, D., & Dieterich, W. (2018) · Medical Sciences · doi:10.3390/medsci6040092 · Cited by 25
“Recent data also shows that hyperglycemia influences intestinal epithelial permeability and may favor systemic infection and inflammation in obesity and diabetes [19].”
BackgroundYou, Q., Dong, H., Shu, G., Cao, B., Xia, Y., Xing, Y., Ni, M., Chen, J. F., Shi, S. L., Gu, H. F., et al. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12892 · Cited by 23
“Because hyperglycemia can drive intestinal barrier dysfunction,(20) gut leakage is a widespread phenomenon in diabetes patients, and increased intestinal permeability can disrupt the internal environment and elevate the risk of T1D development.(21) Significantly increased zonulin and LPS concentrations were found in T…”
BackgroundCourtney, C. M., Onufer, E. J., McDonald, K. G., Steinberger, A. E., Sescleifer, A. M., Seiler, K. M., Tecos, M. E., Newberry, R. D., & Warner, B. W. (2020) · Journal of Surgical Research · doi:10.1016/j.jss.2020.08.049 · Cited by 24
Sholl, J., Mailing, L. J., & Wood, T. R. (2021) · mBio · doi:10.1128/mbio.00579-21 · Cited by 24
“This is likely to be a consequence, rather than a cause, of the metabolic endotoxemia associated with metabolic syndrome and cardiovascular disease, with poor systemic health subsequently impairing gut barrier function (160).”
BackgroundVaccarin enhances intestinal barrier function in type 2 diabetic mice
Sun, J., Yu, X., Hou, B., Ai, M., Qi, M., Ma, X., Cai, M.-J., Gao, M., Cai, W.-W., Ni, L., et al. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174375 · Cited by 23
Hyperuricemia drives intestinal barrier dysfunction by regulating gut microbiota
Yang, X., Liu, D., Zhao, X., Han, Y., Zhang, X., Zhou, Q., & Lv, Q. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e36024 · Cited by 21
Chamseddine, D., Mahmud, S. A., Westfall, A. K., Castoe, T. A., Berg, R. E., & Pellegrino, M. W. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111789 · Cited by 22
“53 Our transcriptomic analyses identified many genes that show significant differential expression with the loss of ATF5.”
InfluentialLiang, Q., Zheng, Y., Meng, F., Jiang, X., Zhen, Q., Lu, Z., Zhang, S., Du, L., Wu, H., & Guo, X. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250073 · Cited by 23
Monocyte regulation by gut microbial signals
Kolypetri, P., & Weiner, H. L. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2023.05.006 · Cited by 21
Tang, X., Beukema, M., Ferrari, M. D. L., Walvoort, M. T. C., de Haan, B. J., & de Vos, P. (2023) · Food & Function · doi:10.1039/d3fo01436c · Cited by 22
Ye, X., Wang, Y., Tian, Y., Bi, R., Li, M., Yang, C., Zhang, L., & Gao, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27478 · Cited by 24
“Recent evidence suggests that hyperglycemia is associated with a decrease in epithelial barrier function [18,19].”
BackgroundBernard, H., Teijeiro, A., Perez, A. C., Perna, C., Satish, B., Novials, A., Wang, J. P., & Djouder, N. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100125 · Cited by 24
“Recombinant DNA pGEX-4T-1-URI (1-267) This Paper N/A”
BackgroundS3QELs protect against diet‐induced intestinal barrier dysfunction
Watson, M. A., Pattavina, B., Hilsabeck, T. A. U., Lopez-Dominguez, J. A., Kapahi, P., & Brand, M. D. (2021) · Aging Cell · doi:10.1111/acel.13476 · Cited by 22
“Three interrelated candidate mechanisms are ER stress (Gulhane et al., 2016) and hyperglycemia (Thaiss et al., 2018), both known to induce mitochondrial ROS production, and stabilization of Hif- 1α in response to superoxide/hydrogen peroxide produced from site IIIQo (Bell et al., 2007; Brunelle et…”
BackgroundLi, X., Liu, L., Liang, X.-Q., Li, Y., & Wang, D. (2022) · International Journal of Surgery · doi:10.1016/j.ijsu.2021.106215 · Cited by 23
Cao, S., Shaw, E. L., Quarles, W. R., Sasaki, G. Y., Dey, P., Hodges, J. K., Pokala, A., Zeng, M., & Bruno, R. S. (2022) · Nutrients · doi:10.3390/nu14081545 · Cited by 22
“Hyperglycemia was also demonstrated to be causally responsible for driving intestinal permeability and the influx of microbial products to the systemic circulation [59].”
BackgroundIntestine‐on‐a‐chip for intestinal disease study and pharmacological research
Zhang, D., & Qiao, L. (2022) · View · doi:10.1002/viw.20220037 · Cited by 20
Song, Q., Cheng, S. W., Zou, J., Li, K. S. L., Cheng, H., Lau, D. T. W., Han, Q., Yang, X., Shaw, P. C., & Zuo, Z. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117437 · Cited by 20
Zhang, H., Lin, Y., Li, S., Bi, J., Zeng, J., Mo, C., Xu, S., Jia, B., Lu, Y., Liu, C., et al. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127788 · Cited by 21
Regulation of splenic monocyte homeostasis and function by gut microbial products
Kolypetri, P., Liu, S., Cox, L. M., Fujiwara, M., Raheja, R., Ghitza, D., Song, A., Daatselaar, D., Willocq, V., & Weiner, H. L. (2021) · iScience · doi:10.1016/j.isci.2021.102356 · Cited by 21
Metadata
- Authors
- Thaiss, C. A., Levy, M., Grosheva, I., Zheng, D., Soffer, E., Blacher, E., Braverman, S., Tengeler, A. C., Barak, O., Elazar, M., Ben-Zeev, R., Lehavi-Regev, D., Katz, M. N., Pevsner-Fischer, M., Gertler, A., Halpern, Z., Harmelin, A., Aamar, S., Serradas, P., Grosfeld, A., Shapiro, H., Geiger, B., & Elinav, E.
- Affiliations
- Weizmann Institute of Science (IL)
- Hebrew University of Jerusalem (IL)
- Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
- Tel Aviv Sourasky Medical Center (IL)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Elinav, Eran
- ORCID
- Venue
- Science
- Published
- 2018-03-23
- Volume
- 359
- Issue
- 6382
- Pages
- 1376-1383
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2794419196
- Cited by
- 942
- References
- 56
- Citations by year
- 2026: 91 · 2025: 134 · 2024: 129 · 2023: 102 · 2022: 142 · 2021: 126 · 2020: 102 · 2019: 74 · 2018: 38
- FWCI
- 30.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Science (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Bill & Melinda Gates Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- hyperglycemia, intestinal barrier dysfunction, gastrointestinal infections, obesity, diabetes mellitus, GLUT2, intestinal epithelial cells, tight junctions, adherens junctions, intestinal permeability, microbial translocation, HbA1c, glycemic control, gut microbiota, systemic inflammation
- MeSH terms
- Gastrointestinal Microbiome, Animals, Blood Glucose, Diabetes Mellitus, Experimental, Escherichia coli Infections, Glucose, Humans, Hyperglycemia, Intestinal Diseases, Intestinal Mucosa, Mice, Inbred Strains, Obesity, Permeability, Streptozocin, Gene Deletion, Caco-2 Cells, Citrobacter rodentium, Glucose Transporter Type 2, Mice, Enteropathogenic Escherichia coli, Receptors, Leptin, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.